ACM
MRNA icon

Atika Capital Management’s Moderna MRNA Stock Holding History

Atika Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-760
Closed -$2.24M – 83
2025
Q4 		$2.24M Buy
+760
New +$20.6K 0.24% 72
2024
Q3 		– Sell
-400
Closed -$4.75M – 104
2024
Q2 		$4.75M Buy
+400
New +$50.6K 0.47% 65
2021
Q1 		– Sell
-109,500
Closed -$11.4M – 112
2020
Q4 		$11.4M Buy
+109,500
New +$11.1M 0.9% 55

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atika Capital Management's MRNA Position: Q1 2019 in Review

Atika Capital Management sold out of Moderna (MRNA) in Q1 2019, closing a stake of 10,000 shares — an estimated $153K sold.

Atika Capital Management first reported a position in MRNA in Q4 2018 and held it in 1 quarter. The position peaked at $153K in Q4 2018. 106 funds tracked by Wall St. Rank hold MRNA as of Q1 2019.

  • Atika Capital Management reported no remaining Moderna position as of Q1 2019 after selling out during the quarter.
  • Atika Capital Management sold 10,000 Moderna shares in Q1 2019, an estimated $153K.
  • Atika Capital Management first reported a position in Moderna in Q4 2018 and held it in 1 quarter.
  • Atika Capital Management's Moderna position peaked at $153K in Q4 2018.
  • 106 funds tracked by Wall St. Rank held Moderna as of Q1 2019.

Based on Atika Capital Management's 13F filing for Q1 2019, filed 13 May 2019.